A reversible monoamine oxidase inhibitor (MAOI) selective for isoform A (RIMA) used to treat major depressive disorder. Most meta-analyses and most studies indicate that in the acute management of depression, moclobemide is more efficacious than placebo medication and similarly efficacious as tricyclic antidepressants (TCA) or selective serotonin reuptake in...
For the treatment of major depressive disorder and bipolar disorder .
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.